低成本无线近红外光谱设备检测下肢动脉粥样硬化并评估外周动脉疾病行走障碍
本研究纳入40例外周动脉疾病(PAD)患者和10名对照,使用低成本无线近红外光谱(NIRS)设备连续测量运动时腓肠肌氧饱和度(StO2)。PAD患者运动后StO2下降更早、幅度更大,且与行走能力显著相关,提示该设备有望用于PAD评估。
要点
- PAD患者运动时腓肠肌StO2下降早于对照(中位1秒 vs 104秒,P<.0001)。
- PAD患者1分钟运动StO2变化百分比与峰值步行时间、6分钟步行距离强相关。
- 低成本无线NIRS设备可区分PAD与健康对照,并反映行走障碍严重程度。
核心结论
- 低成本无线NIRS设备测量的腓肠肌StO2在PAD患者中呈现特征性变化,可区分PAD与健康对照,并与行走障碍强相关。
研究设计与样本
- 研究纳入40例PAD患者和10名对照参与者;PAD患者完成CT血管造影、6分钟步行试验和标准化平板试验,对照完成540秒平板试验。
主要发现
- PAD患者跛行起始时间中位108秒,峰值步行时间中位288秒。
- PAD与对照基线StO2相似;运动后StO2低于基线的中位时间分别为1秒和104秒(P<.0001)。
- PAD患者达到最低StO2的时间早于对照(119秒 vs 522秒,P<.001)。
- 运动1分钟StO2变化百分比为-73.2% vs 8.3%(P<.0001),最低运动StO2降幅为-83.4% vs -16.1%(P<.0001)。
- PAD患者峰值步行时间和6分钟步行距离与运动1分钟StO2变化百分比相关(r=-0.76和-0.67,P<.001),与达到最低StO2时间相关(r=0.79和0.70,P<.0001)。
临床怎么用
- 该低成本无线NIRS设备有望用于PAD的评估、诊断和治疗反应监测,但需进一步研究验证。
局限性
- 本研究为初步评估,样本量有限(40例PAD和10名对照),需进一步研究确认临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with peripheral artery disease (PAD) who experience intermittent claudication report a range of symptoms. Patients with symptoms other than classically described intermittent claudication may be at the highest risk for functional decline and mobility loss. Therefore, technologies allowing for characterization of PAD severity are desirable. Near-infrared spectroscopy (NIRS) allows for measurements of muscle heme oxygen saturation (StO2) during exercise. We hypothesized lower extremities affected by PAD would exhibit distinct NIRS profiles as measured by a low-cost, wireless NIRS device and that NIRS during exercise predicts walking limitation. METHODS: We recruited 40 patients with PAD and 10 control participants. All patients with PAD completed a computed tomographic angiography, 6-minute walk test, and a standardized treadmill test. Controls completed a 540-second treadmill test for comparison. StO2 measurements were continuously taken from the gastrocnemius during exercise. Variables were analyzed by Fischer's exact, χ2, Wilcoxon rank-sum, and Kruskal-Wallis tests as appropriate. Correlations were assessed by partial Spearman correlation coefficients adjusted for occlusive disease pattern. RESULTS: Patients with PAD experienced claudication onset at a median of 108 seconds with a median peak walking time of 288 seconds. The baseline StO2 was similar between PAD and control. The StO2 of PAD and control participants dropped below baseline at a median of 1 and 104 seconds of exercise, respectively (P < .0001). Patients with PAD reached minimum StO2 earlier than control participants (119 seconds vs 522 seconds, respectively; P < .001) and experienced a greater change in StO2 at 1 minute of exercise (-73.2% vs 8.3%; P < .0001) and a greater decrease at minimum exercise StO2 (-83.4% vs -16.1%; P < .0001). For patients with PAD, peak walking time, and 6-minute walking distance correlated with percent change in StO2 at 1 minute of exercise (r = -0.76 and -0.67, respectively; P < .001) and time to minimum StO2 (r = 0.79 and 0.70, respectively; P < .0001). CONCLUSIONS: In this initial evaluation of a novel, low-cost NIRS device, lower extremities affected by PAD exhibited characteristic changes in calf muscle StO2, which differentiated them from healthy controls and were strongly correlated with walking impairment. These findings confirm and expand on previous work demonstrating the potential clinical value of NIRS devices and the need for further research investigating the ability of low-cost NIRS technology to evaluate, diagnose, and monitor treatment response in PAD.
引用
- Fuglestad MA, Hernandez H, Gao Y, et al. A low-cost, wireless near-infrared spectroscopy device detects the presence of lower extremity atherosclerosis as measured by computed tomographic angiography and characterizes walking impairment in peripheral artery disease. J Vasc Surg. 2019. PMID: 31445826. doi:10.1016/j.jvs.2019.04.493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。